Condition: Acute Lymphoblastic Leukemia · T-cell Lymphoblastic Lymphoma · Sponsor: University of Chicago
This is a single center 2-phase study to assess effects of using text messages on adherence to oral chemotherapy for patients with acute lymphoblastic leukemia (ALL) or T-cell lymphoblastic lymphoma.
This description comes directly from the study's public registry record.
Clinical Trials Intake · 1-855-702-8222 · cancerclinicaltrials@bsd.uchicago.edu
Always discuss trial participation with your own doctor first.
| University of Chicago Medicine Comprehensive Cancer Center | Chicago, Illinois, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06446661